160 related articles for article (PubMed ID: 37219637)
1. Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVATTL Pro 3 Study.
Martín-Salvago MD; Sancho M; López-García MÁ; Cano Jiménez A; Pérez-Luque A; Alfaro L; Vieites B
Breast Cancer Res Treat; 2023 Jul; 200(2):203-215. PubMed ID: 37219637
[TBL] [Abstract][Full Text] [Related]
2. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.
Bernet-Vegué L; Cantero-González C; Sancho de Salas M; Parada D; Perin T; Quintero-Niño Z; Vieites Pérez-Quintela B; Sánchez-Guzmán D; Castelvetere M; Hardisson Hernaez D; Martín-Salvago MD
Clin Transl Oncol; 2024 May; 26(5):1220-1228. PubMed ID: 38070048
[TBL] [Abstract][Full Text] [Related]
3. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study.
Vieites B; López-García MÁ; Martín-Salvago MD; Ramirez-Tortosa CL; Rezola R; Sancho M; López-Vilaró L; Villardell F; Burgués O; Fernández-Rodriguez B; Alfaro L; Peg V
Clin Transl Oncol; 2021 Jul; 23(7):1377-1385. PubMed ID: 33517542
[TBL] [Abstract][Full Text] [Related]
4. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.
Martínez M; Jiménez S; Guzmán F; Fernández M; Arizaga E; Sanz C
Breast J; 2022; 2022():6111907. PubMed ID: 35855102
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
[TBL] [Abstract][Full Text] [Related]
7. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
[TBL] [Abstract][Full Text] [Related]
8. Total Tumor Load to assist in the decision for additional axillary surgery in the positive sentinel node breast cancer patients.
Sousa N; Peleteiro B; Fougo JL
Surg Oncol; 2022 Dec; 45():101882. PubMed ID: 36395579
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative Molecular Analysis of Total Tumor Load in Sentinel Lymph Node: A Predictor of Axillary Status in Early Breast Cancer.
Laohawiriyakamol S; Mahattanobon S; Puttawibul P
Asian Pac J Cancer Prev; 2022 Jan; 23(1):349-354. PubMed ID: 35092404
[TBL] [Abstract][Full Text] [Related]
10. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
Breast Cancer Res Treat; 2017 May; 163(1):93-101. PubMed ID: 28213781
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in patients with node-positive breast cancer who undergo sentinel lymph node biopsy alone after neoadjuvant chemotherapy: meta-analysis.
Keelan S; Boland MR; Ryan ÉJ; Moran LR; Davey MG; Lloyd AJ; Elwahab S; Hill ADK
Br J Surg; 2023 Feb; 110(3):324-332. PubMed ID: 36512473
[TBL] [Abstract][Full Text] [Related]
12. Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.
Gao W; Lu S; Zeng Y; Chen X; Shen K
Breast Cancer Res Treat; 2022 Nov; 196(1):129-141. PubMed ID: 36076127
[TBL] [Abstract][Full Text] [Related]
13. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
[TBL] [Abstract][Full Text] [Related]
14. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
[TBL] [Abstract][Full Text] [Related]
16. Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?
Lu X; He M; Yu L; Gou Z
Cancer; 2023 May; 129(10):1492-1501. PubMed ID: 36807239
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes.
Aragon-Sanchez S; Oliver-Perez MR; Madariaga A; Tabuenca MJ; Martinez M; Galindo A; Arroyo ML; Gallego M; Blanco M; Ciruelos-Gil EM
Breast J; 2022; 2022():1507881. PubMed ID: 36051467
[TBL] [Abstract][Full Text] [Related]
18. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
[TBL] [Abstract][Full Text] [Related]
19. Comparison of survival outcomes for axillary surgery extent based on intraoperative sentinel lymph node biopsy result after neoadjuvant chemotherapy for breast cancer.
Chun JW; Kim J; Chung IIY; Ko BS; Kim HJ; Lee JW; Son BH; Ahn SH; Lee SB
Breast Cancer Res Treat; 2021 Jun; 187(3):647-655. PubMed ID: 33966181
[TBL] [Abstract][Full Text] [Related]
20. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
